Find trials
Search tips

Opioid Use After PCNL

Overview

About this study

The purpose of the study is to assess patients’ use of opioid and non-opioid pain medication following percutaneous nephrolithotomy, as well as to characterize disposal patterns for unused opioid medication after recovery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults ≥ 18 years old.
  • Undergoing percutaneous nephrolithotomy at Mayo Clinic Rochester.

Exclusion Criteria:

  • Patients who require Intensive Care Unit admission after surgery.
  • Patients who have Clavien grade III or greater postoperative complications requiring additional intervention < 30 days after index procedure.

Eligibility last updated 8/26/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kevin Koo, M.D., M.P.H.

Closed for enrollment

Contact information:

Kevin Koo M.D., M.P.H.

(507) 293-2501

Koo.Kevin@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20520408

Mayo Clinic Footer